Physician profile
Erika E Reid
NPI 1770882045
$711.47
in general payments reported to CMS, 2019-2025
21 companies · $80.40 in 2025
The $80.40 reported for 2025 was less than what a typical Clinical & Laboratory Dermatological Immunology provider received nationally (typical 2025 total: $1,130).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $164 · 2022: $78.76 · 2023: $112 · 2024: $101 · 2025: $80.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $149.11 | 2020 | |
| Genzyme Corporation | $115.67 | 2019-2025 | |
| Abbvie INC. | $69.88 | 2019-2024 | |
| Ucb, INC. | $53.37 | 2019-2024 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $50.46 | 2019-2023 | Dupixent |
| Janssen Biotech, INC. | $33.24 | 2022-2024 | Tremfya |
| Arcutis Biotherapeutics, INC. | $33.24 | 2025 | Zoryve |
| Galderma Laboratories, L.P. | $22.69 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.49 | 2023 | Spevigo |
| Leo Pharma INC. | $19.11 | 2024 | Adbry |
| Dermavant Sciences, INC. | $15.50 | 2023 | Vtama |
| Amgen INC. | $15.00 | 2020 | |
| Sun Pharmaceutical Industries INC. | $14.87 | 2019 | |
| Biofrontera INC. | $14.59 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Celgene Corporation | $14.29 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $14.07 | 2025 | Gomekli |
| Smith+Nephew, INC. | $13.84 | 2025 | Collagenase Santyl |
| E.R. Squibb & Sons, L.L.C. | $13.47 | 2023 | Sotyktu |
| Helsinn Therapeutics (U.S.), INC. | $13.39 | 2023 | Valchlor |
| Pfizer INC. | $11.45 | 2019 | |
| Organon LLC | $2.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Reid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.